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Abstract
Human gammaherpesviruses are associated with the development of lymphomas and epithelial malignancies. The
heterogeneity of these tumors reflects the ability of these viruses to route infection to different cell types at various stages
of their lifecycle. While the Epstein Barr virus uses gp42 – human leukocyte antigen class II interaction as a switch of cell
tropism, the molecular mechanism that orientates tropism of rhadinoviruses is still poorly defined. Here, we used bovine
herpesvirus 4 (BoHV-4) to further elucidate how rhadinoviruses regulate their infectivity. In the absence of any gp42
homolog, BoHV-4 exploits the alternative splicing of its Bo10 gene to produce distinct viral populations that behave
differently based on the originating cell. While epithelial cells produce virions with high levels of the accessory envelope
protein gp180, encoded by a Bo10 spliced product, myeloid cells express reduced levels of gp180. As a consequence, virions
grown in epithelial cells are hardly infectious for CD14+ circulating cells, but are relatively resistant to antibody
neutralization due to the shielding property of gp180 for vulnerable entry epitopes. In contrast, myeloid virions readily
infect CD14+ circulating cells but are easily neutralized. This molecular switch could therefore allow BoHV-4 to promote
either, on the one hand, its dissemination into the organism, or, on the other hand, its transmission between hosts.
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Introduction
Gammaherpesviruses are ubiquitous pathogens in human and
animal populations all over the world. The best studied gamma-
herpesviruses, the Epstein-Barr virus (EBV) and the Kaposi’s
sarcoma-associated herpesvirus (KSHV), infect respectively some
90% [1] and 30% [2] of human populations. Primary infections by
these viruses are usually subclinical, however, long-term carriage
of these viruses can be associated with the development of various
malignancies [3,4] such as Burkitt lymphoma, nasopharyngal
carcinoma, primary effusion lymphoma or Kaposi’s sarcoma. The
variety of these pathologies reflects the different tropisms of these
viruses for distinct cell types. Understanding how these viruses
orient their tropism is therefore essential for the development of
efficient antiviral strategies and approaches to control the
consequences of these infections.
Attachment to and penetration into the host cells are two
distinct events in herpesvirus entry [5,6]. As enveloped viruses,
gammaherpesviruses enter cells by fusion with a cell membrane.
While the precise mechanism of action is still unclear, the core
fusion machinery is closely conserved and made of gB, gH and gL
[6], although gL can be non-essential [7]. In contrast, the
glycoproteins that mediate attachment and trigger fusion differ
between viral species and also differ for the same virus depending
on its target cell. This is well described for EBV, which for the
most part infects epithelial cells and B lymphocytes [8]. Gp350 is
the most abundant protein of the EBV envelope and is responsible
for the attachment of the virus with high affinity to B cells [9]. On
the opposite, gp350 deleted viruses are more infectious for
epithelial cells [10], and gp350-specific antibodies enhance
epithelial cell infection [11]. In addition to gp350, gp42 can
function as a switch for EBV tropism. Gp42 binds to the human
leukocyte antigen (HLA) class II [12], and determination of gp42
structures in its bound [13] and unbound [14] forms has made
possible the development of a model for understanding how gp42
functions as a fusion activator. However, EBV makes both three-
part gH/gL/gp42 complexes and two-part gH/gL complexes
[15]. While fusion with a B cell is triggered by an interaction
between gp42 and HLA class II [16,17], entry into epithelial cells
requires complexes without gp42 [15]. Interestingly, HLA class II
expression in the virus-producing cells alters the ratio of three-part
to two-part complexes. Therefore, virus produced in epithelial cells
is more infectious for B cells whereas B-cell-derived virus is more
infectious for epithelial cells [18]. Presumably, this switch in
tropism favors the movement between epithelial cells and B cells
during the cycle of persistence [19].
The mechanisms that regulate cell tropism are less clear for
KSHV and other rhadinoviruses such as murid herpesvirus 4
(MuHV-4) or bovine herpesvirus 4 (BoHV-4). However, while
these viruses do not have any gp42 homolog, they all encode a
virion glycoprotein positionally homologous to EBV gp350/220
(BLLF1 gene). These proteins are K8.1A encoded by K8.1 in
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KSHV [20], gp150 encoded by MuHV-4 M7 [21] and gp180
encoded by BoHV-4 Bo10 [22]. Similarly to gp350, these proteins
are involved in binding to some receptors on target cells. Indeed,
K8.1A, gp150 and gp180 interact with glycosaminoglycans
(GAGs) [22–24]. Moreover, these proteins seem to block the
infection of cells that do not express this receptor [22,23]. It has
therefore been proposed that these proteins might regulate viral
tropism both positively and negatively depending on the presence
or the absence of their receptor [22,23,25]. While this putative
model explains GAG+ cells infection, it does not encompass
explanation of the infection of GAG-, cells such as B cells or
monocytes, which are the cells that participate in the dissemina-
tion of these viruses in vivo [26,27]. Therefore the question of how
rhadinoviruses infect these cells remains controversial.
In this study, we showed that the BoHV-4 Bo10 gene encodes
two different mRNAs through alternative splicing and that the
cell-type regulated expression of one or the other transcript leads
to production of virions that are phenotypically distinct. Thus,
similarly to EBV, BoHV-4 progenies derived from different cell
types differ in their cell tropism. Moreover, they also differ in their
susceptibility to neutralizing antibodies. While epithelial virions
are hardly infectious for circulating cells, they are relatively
resistant to neutralization. In contrast, myeloid virions readily
infect CD14+ circulating cells but are easily neutralized. We
therefore propose that by regulating Bo10 mRNA splicing, BoHV-
4 could promote either, on the one hand, its dissemination into the
organism, or, on the other hand, its transmission between hosts.
Results
Bo10 mRNA undergoes alternative splicing
Initial DNA sequence analysis of the BoHV-4 genome identified
an ORF between ORF50 and ORF52 that was made of two exons
[28]. With respect to its relative position in the genome, Bo10 is
therefore similar to K8.1 of KSHV [20] and BLLF1 of EBV [29].
These two genes encode transmembrane glycoproteins that have
been shown to be translated from a spliced message. Recently, we
demonstrated that a Bo10 mRNA splicing removes 77 nucleotides
and generates an mRNA encoding a 273 aa protein with a signal
sequence and a membrane anchor [22]. Interestingly, sequence
analysis revealed the presence of an in-frame STOP codon inside
the Bo10 intron (Figure 1A) that could generate a protein
(Figure 1B) similar to the potential expression product of the
K8.1c message [20]. To verify the transcription of this unspliced
Bo10 message during the BoHV-4 cycle, we used RT-PCR with
different pairs of primers (Figure 1C) on cDNA from BoHV-4
infected Madin-Darby bovine kidney (MDBK) cells. Primers
spanning the intron revealed the existence of two different Bo10
messages. As previously described, the major 739 bp PCR product
(Figure 1C) corresponded to the expected size of the product
generated from the spliced mRNA. However, although weaker, an
unspliced PCR product (817 bp) was also detectable (Figure 1C).
RT-PCR with primer pairs specific to either the spliced or the
unspliced sequence confirmed the existence of both Bo10
messenger RNAs (Figure 1C). None of the fragments could be
amplified without prior reverse transcription (Neg. control lines)
and DNA sequencing confirmed the identity of the different PCR
products (data not shown). Altogether, these results demonstrate
that the BoHV-4 Bo10 gene undergoes alternative splicing.
Generation of the Bo10 MuDir and spliced BoHV-4
mutants
We previously described two BoHV-4 Bo10 knockout strains
[22,30]. To unravel the function of both the spliced and the
unspliced Bo10 expression products, we generated two additional
Bo10 mutant viruses. In the Bo10 MuDir mutant, we punctually
mutated the Bo10 splicing donor site (T to G) to only express the
unspliced form. In contrast, the Bo10 Spliced strain only expresses
the Bo10 spliced product (Figure 2A). Southern blots of viral DNA
(Figure 2B) confirmed the expected genomic structures of the two
mutants and their associated revertant strains. The expected
mutations were further confirmed by DNA sequencing (data not
shown). As expected, RT-PCR analysis showed that the Bo10
MuDir and the Bo10 Spliced strains express the unspliced or the
spliced messenger RNA respectively (Figure 2C). Finally, immu-
noblotting with an anti-Bo10-c15 rabbit polyserum confirmed that
only the Bo10 MuDir mutant virions lacked gp180, encoded by
the spliced Bo10 product (Figure 2D) while content of other
proteins such as gB appeared to be normal (Figure S1).
Effect of Bo10 mRNA splicing on BoHV-4 replication in vitro
We previously showed that the Bo10 knockout strains display a
growth deficit associated with reduced binding to epithelial cells.
We interpreted this phenotype as being a consequence of the
absence of the gp180 glycoprotein that is encoded by the Bo10
spliced message. However, as the Bo10 gene encodes two different
transcripts, this growth deficit could also be associated with the
absence of the unspliced Bo10 message. To address this question,
multi-step growth assays were performed on MDBK cells with the
different Bo10 mutants. Interestingly, only the Bo10 MuDir virus
grew to lower titers than the WT BAC parental strain (Figure 3A).
Enhanced infection of GAG2 cells by the BoHV-4 Bo10
MuDir strain
With the Bo10 knockout strains, we interpreted the growth
deficit on epithelial cells as a consequence of reduced binding to
GAG [22]. Moreover, we showed that Bo10 deletion enhanced
infection of GAG-deficient cells [22]. We therefore compared the
relative dependence on GAGs of the different BoHV-4 strains
constructed in this study by infecting CHO-K1 fibroblasts
competent or not for GAG expression (Figure S2). As observed
with the Bo10 deficient-viruses, Bo10 MuDir virions infected
CHO GAG+ cells similarly to the WT virus but infected CHO
GAG2 cells much better (Figure S2). The Bo10 spliced virions
(expressing gp180) behaved similarly to WT virions (Figure S2). In
vivo, BoHV-4 infects monocytes, which are, however, relatively
GAG deficient [31]. We therefore compared the capacity of the
different viruses to infect rabbit (Figure S3) and cow (Figure 3B)
peripheral blood mononuclear cells (PBMCs) ex vivo. While all the
other strains infected rabbit and cow CD14+ PBMCs very poorly,
Bo10 MuDir viruses infected them much better (Figure S3 and 3B).
Author Summary
Gammaherpesviruses are highly prevalent human and
animal pathogens. These viruses display sophisticated
entry mechanisms, allowing them to infect different cell
types inside a host but also to transmit between hosts in
the presence of neutralizing antibodies. Here, we used
bovine herpesvirus 4 (BoHV-4) to decipher how some
gammaherpesviruses manage to do this. We found that, as
function of the originating cell types, BoHV-4 is able to
modify its tropism as well as its sensitivity to antibody
neutralization just by controlling the alternative splicing of
one of its genes. This virus therefore exploits post-
transcriptional events to generate viral populations with
distinct phenotypes.
Alternative Splicing Regulates Viral Tropism
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Bo10 splicing regulates BoHV-4 antigenicity and
susceptibility to neutralization
We have previously shown that gp180 provides part of a glycan
shield for otherwise vulnerable viral epitopes [30]. Indeed,
antibodies have greater access to gB, gH and gL on Bo10
knockout virions and this correlates with a greater susceptibility to
neutralization by immune sera [30]. As we have shown that Bo10
encodes two transcripts, we used Bo10 spliced and Bo10 MuDir
mutants to investigate which of these transcripts is responsible for
antibody evasion. Infected cell surfaces provide a means of probing
antigenic differences between BoHV-4 glycoprotein mutants. We
therefore compared epitope accessibility on cells infected by the
different BoHV-4 Bo10 mutant viruses. Only the cells infected by
the Bo10 MuDir and Stop mutants were more heavily stained with
mAb 29 recognizing gB (Figure 3C). This result was not due to
differences in protein expression, as permeabilized cells gave
similar staining with each virus (Figure 3C). It therefore appears
that only the spliced Bo10 transcript, encoding gp180, is involved
in shielding other epitopes at the cell surface.
We therefore further compared the sensitivity of BoHV-4 WT
BAC, Bo10 STOP, Bo10 MuDir and Bo10 Spliced strains to
neutralization by sera of rabbits infected with the BoHV-4 V.test
strain (Figure 3D). WT and Bo10 Spliced virions were poorly
neutralized. In contrast, Bo10 STOP and Bo10 MuDir virions were
much more efficiently neutralized. Especially, complete neutraliza-
tion was now possible. Thus, Bo10 splicing and the subsequent
gp180 expression are critical to limiting virion neutralization.
Bovine epithelial and myeloid cells produce different
kinds of BoHV-4 virions
Different bovine cell lines were then investigated for expression
of Bo10 spliced and unspliced transcripts by quantitative PCR. In
Figure 1. Bo10 mRNA undergoes alternative splicing. A. Nucleotide sequence of BoHV-4 Bo10. The underlined nucleotides represent the
sequence encoding the predicted signal peptide. The boxes indicate the splicing donor and acceptor sites. The sequence in red italics indicates the
nucleotides removed after splicing. Nucleotides in green indicate the STOP codon in the intron. B. Amino acid comparisons of the predicted spliced
and unspliced Bo10 products. The red amino acids represent the signal peptide sequence. The green amino acids indicate the predicted
transmembrane region of the Bo10 spliced expression product. Serines and threonines are highlighted in bold. C. RT-PCR analysis of the BoHV-4 Bo10
reading frame. MDBK cells were mock infected or infected with the BoHV-4 V.test strain at a MOI of 1. Twenty-four hours p.i., expression of Bo10 was
studied using different pairs of primers specific for the spliced and/or the unspliced Bo10 products. Red arrows indicate locations of the different
primers. Uninfected cell samples (UI), reactions without reverse transcriptase (Neg. control) and amplification of viral genomic DNA are provided as
controls. Sizes in bp are indicated on the right.
doi:10.1371/journal.ppat.1003753.g001
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order to be able to compare the numbers of both transcripts, a
plasmid encoding both Bo10 spliced and unspliced specific
sequences was constructed and used as a unique standard curve
for both reactions. Interestingly, while the infected epithelial
MDBK cells displayed around 1000 times more Bo10 spliced
transcript than unspliced transcript, this ratio was more than 10
times lower in the BoMac myeloid cells (Figure 4A). We then
compared the number of Bo10 spliced transcripts, encoding
gp180, to the number of ORF8 transcripts, encoding gB, as we
have shown that one of the glycoproteins shielded by gp180 is gB
(Figure 3C) [30]. While the infected epithelial MDBK cells
displayed around 10 times more Bo10 spliced transcripts than
ORF8 transcripts, this ratio was around 10 times lower in the
BoMac myeloid cells (Figure 4B), suggesting that in these cells,
there could be less expression of gp180 glycoprotein in comparison
to gB. Similar results were obtained when the amount of Bo10
spliced transcripts was compared to the number of ORF47 mRNA
encoding gL (Figure S4), as gL is another viral glycoprotein
shielded by gp180. Finally, these results were confirmed by
western blotting on MDBK or BoMac cells (Figure 4C). Interest-
ingly, while gB glycoprotein was readily detectable in both cell
types, almost no gp180 glycoprotein was observed in BoHV-4 WT
infected BoMac cells.
Finally, incorporation of gp180 in MDBK and BoMac virions
was assessed by immunoblotting on purified virions. As observed
on infected cells, BoMac virions contain relatively less gp180 than
MDBK virions while amounts of gB appear to be similar (Figure 5).
Blotting with a rabbit polyserum raised against BoHV-4 virions
was used as loading control. These results therefore suggest that
the BoHV-4 phenotype could change with the type of cell in which
it is grown, namely epithelial or myeloid cells.
Phenotypic changes in myeloid cell-derived virions
We first compared phenotypes of MDBK and BoMac derived
virions by co-culture experiments (Figure 6A). While naı¨ve MDBK
cells co-cultured overnight with BoHV-4 WT BAC infected
MDBK cells became .80% eGFP+, CD14+ PBMCs cultured
under the same conditions remained nearly entirely uninfected
(,1% eGFP+) (Figure 6A). In contrast, BoHV-4 WT BAC infected
BoMac cells produced lower amount of virions, as demonstrated
by the fact that only ,20% of co-cultured MDBK cells became
eGFP+. However, these few virions were much more infectious for
CD14+ PBMCs (.10% eGFP+) in comparison with MDBK
derived virions (Figure 6A). Therefore direct contact with infected
myeloid BoMac cells allowed efficient BoHV-4 infection of
circulating CD14+ PBMCs.
We next tested whether cell-free virions derived from myeloid
BoMac cells could also better infect CD14+ PBMCs compared to
cell-free virions derived from epithelial MDBK cells. While
MDBK-derived virions barely infected 0.5% of PBMCs at the
multiplicity of infection (MOI) of 3, according to titers measured
on MDBK cells, BoMac-derived virions infected these cells
substantially more efficiently as around 5% of CD14+ PBMCs
became positive (Figure 6B).
The second phenotypic difference between Bo10 MuDir and
Spliced virions was related to resistance to neutralization by
immune sera. Therefore, we compared sensitivity to serum neutra-
lization of BoHV-4 WT BAC virions derived from MDBK or
BoMac cells. As previously observed [30], MDBK-derived WT
virions were poorly neutralized by immune sera. In contrast,
BoMac-derived WT virions were neutralized much more
efficiently (Figure 6C).
Finally, in order to demonstrate that the phenotypic difference
of BoHV-4 myeloid virions was mainly due to reduced Bo10
mRNA splicing, Bo10 Spliced virions were propagated on BoMac
cells and compared to WT BAC virions derived from MDBK or
BoMac cells (Figure 7). While WT BAC BoMac-derived virions
readily infected CD14+ PBMCs, Bo10 Spliced virions derived
from BoMac cells infected very few CD14+ PBMCs similarly to
WT BAC virions propagated on MDBK cells (Figure 7A).
Moreover, in contrast to BoMac-derived WT virions, Bo10
Spliced virions propagated on BoMac cells resisted neutralization
similarly to BoHV-4 WT BAC virions derived from MDBK cells.
Altogether, these results show that regulation of Bo10 mRNA
splicing offers the possibility of regulating both the tropism and the
antigenicity of BoHV-4 virions.
Discussion
Herpesvirus lifecycles are probably among the most complex
lifecycles of all viruses. Indeed, these viruses are able not only to
engender either latent or lytic infections but are also able to do so
in different cell types at different stages of infection. This is
particularly true of gammaherpesviruses, for which viral replica-
tion in mucosal epithelium appears to be mainly important for
host entry [32] and exit [33,34], whereas latency establishment in
circulating leukocytes ensures host colonization [35]. Infection of
these two key targets has proven to follow substantially different
pathways [8] and regulation of these processes may allow these
viruses to route infection in vivo. For example, EBV appears to use
gp42 as a switch of cell tropism [18]: epithelial cells produce
virions high in gH/gL/gp42 complexes, which promote B-cell
infection, while B cells produce viruses low in gp42, which
efficiently infect epithelial cells but not B cells.
While rhadinoviruses, such as KSHV or BoHV-4, share a
similar alternate tropism in vivo, the mechanisms underlying this
property were still unknown. Thus, BoHV-4 persists in circulating
CD14+ cells in vivo, yet infects them poorly in vitro. In this study, we
showed that alternative splicing of the Bo10 gene defines the cell
tropism of BoHV-4 virions. In addition to the Bo10 spliced
message, that encodes gp180, an unspliced Bo10 mRNA is
Figure 2. Generation of the Bo10 MuDir and Spliced BoHV-4 mutant. A. Schematic representation of the strategy followed to produce the
recombinant BoHV-4 strains. We modified the BoHV-4 V.test Bo10 coding sequence (genomic coordinates 65844 to 66743) either by introducing a
point mutation in the splicing donor site (Bo10 MuDir strain) or by replacing the entire Bo10 ORF by a sequence devoid of the intron (Bo10 Spliced
strain). Splicing donor and acceptor sites are in red with splicing essential nucleotides in upper cases. The mutated nucleotide is in green. B.
Verification of the molecular structure. Viral DNA was digested with BamHI, resolved by agarose gel electrophoresis, and hybridized with a 32P-labeled
probe, corresponding to nucleotides 65900–66370 of the BoHV-4 V.test strain genome (coding for Bo10 Exon 1). The 7,137-bp wild-type (WT) band
becomes 7060-bp (open arrow) for the Bo10 spliced mutant. Marker sizes in Kbp are indicated on the left. C. RT-PCR analysis of BoHV-4 Bo10
expression by the different mutants. MDBK cells were mock infected or infected with the different BoHV-4 mutant strains at a MOI of 1. Twenty-four
hours p.i., expression of Bo10 was studied using different pairs of primers specific for the spliced and/or unspliced Bo10 cDNA. Uninfected cell
samples (UI), reactions without reverse transcriptase (Neg. control) and amplification of viral genomic DNA are provided as controls. Sizes in bp are
indicated on the right. D. Detection of the Bo10 encoded gp180 protein by the anti-Bo10-c15 serum. Purified virions (5*105 virions per lane) were
subjected to western blotting with anti-Bo10-c15 serum as described in the Methods. The position of a molecular mass (MM) standard (in kDa) is
shown on the right.
doi:10.1371/journal.ppat.1003753.g002
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transcribed during the BoHV-4 cycle (Figure 1). Viral strains
expressing one or the other transcript showed different infectivity
patterns associated with GAG expression (Figure S2). Exclusive
expression of the unspliced transcript generated virions that were
both less infectious for GAG+ cells than the wild-type and more
infectious for GAG2 cells. On the opposite, exclusive expression
of the spliced message blocked GAG2 cells infection. Moreover,
relative proportions of these two transcripts determined the release
of distinct viral populations. Epithelial cells, expressing high
amounts of gp180, produced virions that were unable to infect
CD14+ in contrast to virions derived from myeloid cells,
expressing low amounts of gp180 (Figures 4–6).
These results suggest an epithelial/myeloid/circulating leuko-
cyte infection pathway for BoHV-4 (Figure 8), similar to the one
recently described for MuHV-4 [36]. Indeed, we had previously
showed that the BoHV-4 Bo10 gene positively regulates the
Figure 3. Bo10 mRNA splicing determines phenotype of BoHV-4 virions. Effect of Bo10 mRNA splicing on BoHV-4 tropism (A–B) and
antibody recognition (C–D). A. MDBK cells grown in 6-well cluster dishes were infected at a MOI of 0.01 for multi-step assays as described in the
Methods with BoHV-4 WT BAC (black squares), Bo10 MuDir (open circles), Bo10 MuDir Rev (black circles), Bo10 Spliced (open triangles) and Bo10
Spliced Rev (black triangles). Supernatant of infected cultures and infected cells were harvested at different times p.i. and the amount of infectious
virus was determined by plaque assay on MDBK cells. Time 0 p.i. is re-titration of the inocula to ensure that similar amounts of virus were put on the
cells. Plaques were visualized by immunofluorescent staining as described in the Methods. The data presented are the average 6 SEMs for triplicate
measurements. The data were analyzed by 2way ANOVA and Bonferroni posttests, ** p,0.01, *** p,0.001. B. Cattle PBMCs were infected with WT
BAC, Bo10 MuDir, Bo10 MuDir Rev, Bo10 Spliced and Bo10 Spliced Rev strains (1 PFU/cell). Twenty-four hours later, cells were analyzed by flow
cytometry for CD14 and viral eGFP expression as described in the Methods. The data presented are the average 6 SEMs for 6 measurements and
were analyzed by 1way ANOVA and Bonferroni posttests, *** p,0.001. C.MDBK cells were infected (2 PFU/cell, 36 h) with WT (solid black lines), Bo10
STOP (red lines), Bo10 Stop Rev (dotted black lines), Bo10 MuDir (green lines), Bo10 MuDir Rev (grey lines), Bo10 Spliced (dotted grey lines) or Bo10
Spliced Rev (dotted dark grey lines) of BoHV-4 V.test, and then analyzed by flow cytometry for gB detection (mAb 29). The filled histogram shows
uninfected cells (UI). Fixed (PFA 4%, 4uC for 30 min) and permeabilized (saponin 0.1%) cells were used as controls of protein expression. D. BoHV-4
WT BAC, Bo10 STOP, Bo10 MuDir and Bo10 Spliced virions were incubated with sera of 3 different rabbits infected with BoHV-4 V.test strain. After
incubation (2 h, 37uC), the viruses were plaque assayed for infectivity on MDBK cells. BoHV-4 titers are expressed relative to virus without antibody.
The data presented are the average 6 SEMs for 3 measurements and were analyzed by 2way ANOVA and Bonferroni posttests, * p,0.05, ** p,0.01,
*** p,0.001.
doi:10.1371/journal.ppat.1003753.g003
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infection of GAG-bearing cells such as epithelial cells [22]. In this
study we showed that this is through the expression of the Bo10
spliced product, encoding gp180. In vivo, such interaction probably
occurs at specific locations displaying accessible heparin sulfates
structures such as the olfactory neuroepithelium as shown for
MuHV-4 [32]. Replication in epithelial cells likely allows infection
of some myeloid cells which are susceptible to infection by
epithelial virions. Finally, this myeloid infection allows infection of
circulating leukocytes, such as CD14+ cells in the case of BoHV-4.
Interestingly, a similar role of myeloid infection has been proposed
in the case of MuHV-4 [36]. However, differences exist between
the two models. Firstly, MuHV-4 infects mainly circulating B cells.
Secondly, RT-PCR has never demonstrated MuHV-4 gp150
truncation by splicing nor were myeloid cell-derived MuHV-4
virions gp150-deficient [36]. Moreover, the results obtained with
MuHV-4 suggested that the myeloid-derived virions phenotype
could be associated with conformational changes in gB and gH.
While this cannot be excluded in our model, the fact that the
forced expression of gp180 in myeloid cells, as seen with Bo10
Spliced virions (Figure 7), or the absence of expression of gp180 in
epithelial cells, as seen with Bo10 MuDir virions (Figure 3B), is
sufficient to switch cell tropism suggest that Bo10 alternative
splicing is the main determinant of BoHV-4 virion tropism. While
our main hypothesis is that gp180 is directly involved in switching
the tropism of BoHV-4 virions (direct effect), we cannot rule out
that the amount of gp180 that is incorporated in virions affects
either the recruitment of another protein or its conformation
(indirect effect).
Figure 4. BoMac myeloid cells express relatively less gp180 glycoprotein in comparison with epithelial cells. A–B. MDBK and BoMac
cells were infected with the BoHV-4 V.test strain at a MOI of 1. Twenty-four hours p.i., relative expressions of Bo10 spliced vs unspliced transcripts (A)
and of Bo10 spliced vs ORF8 transcripts (B) were estimated as described in the Methods. The data presented are the average 6 SEMs for 3
measurements and were analyzed by Student’s t-test, ** p,0.01. C. Detection of the gp180, encoded by the Bo10 spliced transcript, and gB
glycoproteins in bovine epithelial and myeloid cells. MDBK and BoMac cells were infected with the BoHV-4 V.test strain at a MOI of 1. Twenty-four
hours p.i., these cells were subjected to western blotting with anti-Bo10-c15 serum (recognizing gp180) and mAb 35 (recognizing gB) as described in
the Methods. On the gp180 blot, open and filled triangles indicate respectively the specific 180 kDa protein and a background band. On the gB blot,
open and filled arrow heads indicate uncleaved gB and furin-cleaved gB C-terminus respectively. The position of a molecular mass (MM) standard (in
kDa) is shown on the left.
doi:10.1371/journal.ppat.1003753.g004
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When seen only from the angle of cell tropism, the role of gp180
appears unclear. Indeed, it is unnecessary for growth on epithelial
cells and it negatively regulates infection of GAG2 cells (Figures 3,
S2 and S3). Moreover, a BoHV-4 strain deleted for the Bo10 gene
displays no latency establishment deficit in vivo [30]. Positive
selection pressure for gp180 expression is therefore difficult to
understand in these contexts. As was recently demonstrated for
influenza, the evasion of neutralizing antibodies is one of the main
forces that drive virus evolution [37]. This is particularly true for
gammaherpesviruses that establish lifelong latency and are therefore
continuously shed in the presence of neutralizing antibodies [34]. In
this context, we recently showed that the deletion of BoHV-4 Bo10
gene markedly sensitized virions to neutralization by immune sera.
The results obtained here demonstrate that this phenomenon is
related, either directly or indirectly, to gp180 expression, as only
Bo10 MuDir virions and not Bo10 spliced virions displayed
increased sensitivity to neutralization (Figure 3D). Similarly, WT
virions derived from myeloid cells were more easily neutralized than
epithelial cell-derived WT virions (Figure 6C). Again, this was
associated with reduced expression of the spliced Bo10 transcript, as
the forced expression of gp180 in myeloid cells substantially reduced
sensitivity to neutralization by immune sera (Figure 7B). These
observations make sense in the context of an in vivo cycle as epithelial
cell-derived virions have to face neutralizing antibodies that are
likely to be present at mucosal sites. In contrast, because spread of a
gammaherpesvirus within the host is more likely to involve direct
cell–cell contact [38] rather than cell-free virion release, myeloid
cell-derived virions may not have to face a similar constraint.
Epithelial virions would therefore be better fit for virus transmission
between hosts, while myeloid virions would be more efficient for
host colonization.
A central question about this mechanism is why BoHV-4 uses
alternative splicing of the Bo10 gene instead of expressing gp180
from an unspliced message that would be turned on or off. One of
the reasons could be that the unspliced Bo10 message has its own
function. Thus, as gp180 interacts with GAGs, the potential
soluble form of gp180 could coat the infected cell surface and
therefore promote the release of progeny virions by preventing
their interaction with cell surface GAGs. Interestingly, a truncated
isoform of the major glycoprotein is also secreted from infected
cells during EBOLA virus infection [39]. This protein is involved
in antibody evasion as it not only serves as a decoy for adsorbing
preexisting neutralizing antibodies [40,41] but also contributes to
antigenic subversion of the host immune repertoire [41]. As
antibody evasion is particularly important for gammaherpes-
viruses, the potential soluble form of BoHV-4 gp180 could share
similar roles. This hypothesis would imply that gp180 itself is a
neutralization target. At the moment, this is not known. This will
therefore deserve future studies.
Similar mechanisms could occur in KSHV, where the gp180
homolog is encoded by K8.1. As observed for BoHV-4 Bo10, K8.1
displays several alternative spliced forms [20]. Two proteins,
K8.1A and B, are generated from spliced message and encode
transmembrane glycoproteins that bind to cell surface heparan
sulfate [24,42]. These proteins are thought to be involved in the
initial steps of virion attachment. K8.1 also encodes a third
unspliced message, K8.1c [20], which might likewise code for a
soluble protein. Interestingly, a novel alternative message has also
recently been described for the EBV BLLF1 gene, encoding
gp350/220 [43]. The potential protein encoded by this product
also lacks a transmembrane domain. The usage of alternative
splicing could therefore allow EBV and KSHV to regulate
incorporation of their respective g180 homologs in a similar way to
what we showed for BoHV-4 although other regulation mecha-
nisms may exist. This phenomenon and the potential functional
consequences on EBV or KSHV tropism will have to be tested in
the future.
Deciphering the protein coding complexity of herpesviruses is
far from complete. Numerous reports point to a major role for
regulated use of alternative splicing in enabling tight temporal
control of protein expression and allowing multiple distinct
polypeptides to be generated from a single genomic locus [43–
47]. However, the roles of these splicing events remain largely
unknown. Our results show that alternative splicing of the BoHV-
4 Bo10 gene orientates viral tropism and determines virion
sensitivity to neutralizing antibodies.
Materials and Methods
Viruses
The BoHV-4 V.test strain (WT), was initially isolated from a
case of orchitis [48]. Bo10 Del, Bo10 Stop and the corresponding
Figure 5. Bovine epithelial and myeloid cells produce different
kinds of BoHV-4 virions. Detection of the gp180 and gB
glycoproteins in MDBK and BoMac virions. Different amounts of MDBK
and BoMac virions were compared for gp180 (with anti-Bo10-c15
serum) and gB (with mAb 35) content per PFU by immunoblotting as
described in the Methods. Anti-BoHV-4 polyserum was taken as control.
For each blot, the position of a molecular mass (MM) standard (in kDa)
is shown on the left.
doi:10.1371/journal.ppat.1003753.g005
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Figure 6. Myeloid virions are more infectious for CD14+ PBMCs but are more sensitive to antibody neutralization. A. Infection by co-
cultures. MDBK or BoMac cells previously stained with the membrane dye PKH26 were infected with BoHV-4 WT BAC virions (MOI of 1). Three hours
p.i., cells were washed with acidic solution (PBS pH 3) in order to inactivate and remove the inoculum, and 12 hours p.i., freshly isolated PBMCs or
MDBK controls were added. After 24 hours of co-cultivation, cells were collected and the proportion of eGFP expressing cells was measured in
PKH26+ and PKH262 cells. For PBMC co-cultures, the proportion of eGFP expressing cells was measured in PKH262 CD14+ cells. The data presented
are the average 6 SEMs for 5 measurements and were analyzed by Student’s t-test, *** p,0.001. B. BoHV-4 WT BAC cell-free virions propagated on
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revertant strains have been described previously [22,30]. The other
viruses were derived from a cloned BoHV-4 BAC (WT BAC) [49].
Unless stated otherwise, the viruses were grown on MDBK cells.
Cells
MDBK (ATCC CCL-22) and BoMac [50] cells were cultured
in Dulbecco’s modified Eagle Medium (Invitrogen) containing
10% fetal calf serum (FCS), Penicillin (200 U/mL)/Streptomycin
(200 mg/mL) (Invitrogen) and non-essential amino acids (Invitro-
gen) diluted following the manufacturer’s recommendations.
Bovine and rabbit PBMCs were prepared as described elsewhere
[22]. Briefly, PBMCs were isolated from 10 ml of blood. Mono-
nuclear cell suspensions were prepared with Ficoll-Paque Premium
density gradient media (GE Healthcare) as follows. Cell suspension
in sterile PBS was overlaid onto a 7 ml Ficoll-Paque density
cushion and centrifuged (18256g) for 20 min at room-tempera-
ture. Mononuclear cells at the interface were collected and washed
twice in ice-cold PBS before further analysis. PBMCs were
cultured in RPMI Glutamax Medium containing 10% FCS,
Penicillin (200 U/mL)/Streptomycin (200 mg/mL) (Invitrogen),
non-essential amino acids (Invitrogen) diluted following the
manufacturer’s recommendations, 1 mM Sodium pyruvate,
25 mM HEPES and 50 mM 2-mercaptoethanol.
Antibodies, sera and reagents
For detection of gp180, encoded by the Bo10 spliced transcript,
on western blotting, we used a rabbit monospecific polyserum
raised against the C-term end of the gp180 protein (anti-Bo10-c15)
[22]. Therefore, this polyserum does not recognize the potential
protein encoded by the Bo10 unspliced transcript. The mouse
monoclonal antibodies (mAbs) 29 and 35 were raised against gB
[30]. The mouse anti-human CD14 Pacific Blue was purchased
from Serotec. Rabbit anti-BoHV-4 WT polysera were obtained
previously [30]. The PKH26 Red Fluorescent Cell Linker (Sigma)
was used for general cell membrane labeling.
RT-PCR
Sub-confluent monolayers of MDBK cells were infected at a
MOI of 1 PFU/cell. 24 hours after infection (p.i.), cytoplasmic
RNA was isolated by using RNeasy mini kit (Qiagen). Contam-
inating DNA was removed by DNase treatment. cDNA was
produced by using the First Strand cDNA Synthesis Kit (Roche
Applied Science) with poly d(T) primer. The cDNA products were
amplified by PCR with Taq polymerase (New England Biolabs),
and specific primer pairs. Bo10 23-43 (59-TCATACATT-
CAAATTGCATGC-39) and Bo10 839-818 (59-CATTGAATGA-
GAACAAACACG-39) were used to amplify both transcripts.
MDBK or BoMac cells were added to bovine PBMCs at a MOI of 1 according to titers measured on MDBK cells. 24 hours later, percentages of eGFP
positive cells were measured in CD14+ PBMCs by flow cytometry. The data presented are the average6 SEMs for 5 measurements and were analyzed
by Student’s t-test, *** p,0.001. C. BoHV-4 WT BAC virions propagated on MDBK or BoMac cells were incubated with sera of 3 different rabbits
infected with BoHV-4 V.test strain (propagated on MDBK cells). After incubation (2 h, 37uC), the viruses were plaque assayed for infectivity on MDBK
cells. BoHV-4 titers are expressed relative to virus without antibody. The data presented are the average 6 SEMs for 3 measurements and were
analyzed by 2way ANOVA and Bonferroni posttests, * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.ppat.1003753.g006
Figure 7. Expression of the spliced form of Bo10 mRNA reverts the phenotype of myeloid virions. A. BoHV-4 WT BAC or Bo10 Spliced
virions were propagated on MDBK or BoMac cells and then added to bovine PBMCs at a MOI of 3 according to titers measured on MDBK cells.
24 hours later, percentages of eGFP positive cells were measured in CD14+ PBMCs by flow cytometry. The data presented are the average6 SEMs for
4 measurements and were analyzed by 1way ANOVA and Bonferroni posttests, ** p,0.01. B. BoHV-4 WT BAC or Bo10 Spliced virions propagated on
MDBK or BoMac cells were incubated with sera of 3 different rabbits infected with BoHV-4 V.test strain (propagated on MDBK cells). After incubation
(2 h, 37uC) the viruses were plaque assayed for infectivity on MDBK cells. BoHV-4 titers are expressed relative to virus without antibody. The data
presented are the average 6 SEMs for 3 measurements and were analyzed by 2way ANOVA and Bonferroni posttests, ** p,0.01.
doi:10.1371/journal.ppat.1003753.g007
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Figure 8. BoHV-4 model for switch of cell tropism through alternative splicing of the Bo10 gene. (1) Expression of the Bo10 spliced
product, encoding gp180, positively regulates the infection of GAG-bearing cells. (2) Replication in epithelial cells likely allows infection of myeloid
cells. (3) Myeloid infection allows infection of circulating leukocytes, such as CD14+ cells in the case of BoHV-4. (4) Infected PBMCs transmit infection
to epithelium of the excretion sites by an unknown route. (5) Finally, incorporation of gp180 at the excretion site allows virions to be protected from
neutralizing antibodies.
doi:10.1371/journal.ppat.1003753.g008
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Bo10 PBDF (59-ATGAGGTTAAGAGTCAGATC-39) and Bo10
IntronRev (59-ACCATTTAGTCAAATTCCACAC-39) were used
to amplify unspliced Bo10 product. Bo10 PBDF and Bo10
SplicedOnlyRev (59-GGATGTCTGTGTGCCTGAG- 39) were
used to amplify the spliced Bo10 product.
Mutagenesis
We modified the BoHV-4 V.test Bo10 coding sequence
(genomic coordinates 65844 to 66743) by BAC mutagenesis [49]
to generate two supplemental recombinant viral strains. In the first
one (Bo10 MuDir strain), we introduced a single point mutation in
the splicing donor site. In the second one, we replaced the entire
Bo10 ORF with a sequence devoid of the intron (Bo10 Spliced
strain). The Bo10 MuDir and the Bo10 Spliced strains were
generated by a two-step mutagenesis procedure in bacteria using
the shuttle plasmid pST76KSR [49]. Plasmids to induce
homologous recombination were constructed as follows. For the
Bo10 MuDir strain, we first PCR-amplified (Platinum Taq DNA
Polymerase High Fidelity, Invitrogen) coordinates 65331–67427 of
the BoHV-4 V.test genome, including SacI and XmaI restriction
sites in the respective forward and reverse primers, and T/A
cloned the PCR product into the pGEM-T Easy vector (Promega
Corporation) resulting in pGEM-T Easy Bo10 zone Rec plasmid.
Next, the Bo10 splicing donor site was mutated by site directed
mutagenesis (Quikchange site directed mutagenesis, Stratagene)
resulting in pGEM-T Easy Bo10 zone Rec MuDir plasmid. For
the Bo10 Spliced strain, cDNA was prepared from WT BoHV-4
infected MDBK cells and Bo10 specific sequences were amplified
with Bo10 23-43 and Bo10 839-818 specific primers. The lower
740 bp band was then BstBI/HpaI-restricted and cloned into the
corresponding sites of the pGEM-T Easy Bo10 zone Rec plasmid
resulting in pGEM-T Easy Bo10 zone Rec Spliced plasmid. Each
construct was then subcloned as a SacI/XmaI fragment into the
same sites of the pST76K-SR shuttle vector, and recombined into
the BoHV-4 BAC [49]. In the same way, we also isolated
revertants in which the Bo10 locus was restored to its wild-type
form. Reconstitution of the infectious virus from BAC plasmids
was obtained by transfection in MDBK cells.
Southern blot
Southern blot analysis of viral DNA digested with BamHI was
performed with a probe corresponding to nucleotides 65900–66370
of the BoHV-4 V.test strain genome (coding for Bo10 Exon 1) [51].
Virus purification
BoHV-4 strains grown on MDBK cells were purified as follows.
Briefly, after removal of the cell debris by low-speed centrifugation
(1,0006 g, 10 min at 4uC), virions present in the infected cell
supernatant were harvested by ultracentrifugation (100,0006 g,
2 h at 4uC) through a 30% (wt/vol) sucrose cushion. Virions were
then banded by isopycnic gradient ultracentrifugation in a 20 to
50% (wt/vol) potassium tartrate gradient in PBS (100,0006 g, 2 h
at 4uC). The band containing virions was collected (,3 mL), diluted
ten fold in PBS and pelleted by ultracentrifugation (100,0006g, 2 h
at 4uC). The pellet was finally resuspended in PBS, and virus
enriched preparations were stored at 280uC.
Western blot
Purified virions were lysed and denatured by heating (95uC,
5 min) in SDS-PAGE sample buffer (31.25 mM Tris-HCl pH 6.8,
1% (w/v) SDS, 12.5% (w/v) glycerol, 0.005% (w/v) Bromophenol
Blue, 2.5% (v/v) 2-mercaptoethanol). Proteins were resolved by
electrophoresis on Mini-PROTEAN TGX (Tris-Glycine eXtended)
precast 7.5% resolving gels (Bio-Rad) in an SDS-PAGE running
buffer (25 mM Tris-base, 192 mM glycine, 0.1% (w/v) SDS) and
transferred to polyvinylidene difluoride membranes (Immobilon-P
transfer membrane, 0.45 mM pore size, Millipore). The membranes
were blocked with 3% non-fat milk in PBS/0.1% Tween-20, and then
incubated with the anti-Bo10-c15 rabbit antibodies, with the anti-
BoHV-4 polyserum or with the mAb 35 in the same buffer. Bound
antibodies were detected with horseradish peroxidase-conjugated
goat anti-rabbit IgG pAb or anti-mouse IgG pAb (Dako Corpora-
tion), followed by washing in PBS/0.1% Tween-20, development
with ECL substrate (GEHealthcare) and exposure to X-ray film.
Growth curves
The growth kinetics of mutant and revertant viruses were
compared to that of WT. Cell cultures were infected at a MOI of
0.01 (multi-step assay). After 1 h of adsorption, the cells were
washed and then overlaid with MEM containing 5% FCS.
Supernatants of infected cultures and infected cells were harvested
together at successive intervals and the amount of infectious virus
was determined by plaque assay on MDBK cells [52].
Immunofluorescence
For PBMCs, staining, washes and incubation steps were
performed in FACS buffer (PBS pH 7.4, 0.1% BSA, 0.05%
NaN3). Cells were incubated with Pacific Blue-conjugated anti-
human CD14 (1/50) on ice for 45 min. After washing, cells were
analyzed for eGFP and Pacific-Blue fluorescences. Dead cells were
excluded with 7-AAD staining. For cell surface staining of viral
glycoproteins, cells were infected by the different virus strains at a
MOI of 2 PFU/cell for 36 h. After trypsinization and one wash in
PBS, the cells were stained with monoclonal antibodies in PBS
containing 10% fetal calf serum for 1 h at 4uC. After one wash in
PBS, the cells were incubated with goat anti-mouse IgG-Alexa Fluor
633 (Invitrogen) diluted 1:1,000 in PBS containing 10% FCS for 1 h
at 4uC. After one wash in PBS, the cells were analyzed. For
intracellular staining, cells were fixed in 1% paraformaldehyde
(PFA) for 30 min at room temperature and then permeabilized with
0.1% saponin. Cells were incubated in PBS 10% FCS 0.1% saponin
(1 h, 4uC) with the different mAbs specific for BoHV-4 glycopro-
teins followed by Alexa 633-conjugated goat anti-mouse pAb
(Invitrogen). Cells were then washed and analyzed. All the analyses
were performed on a FACSAria flow cytometer (Becton Dickinson).
Neutralization assays
Neutralization was tested by incubating virus with antibody for
1 h at 37uC before adding the virus/antibody mixtures to MDBK
cells for a further 3 h. The cells were then overlaid with 0.6%
carboxymethylcellulose and the cell monolayers were fixed for
plaque counting (based on eGFP expression) after a further 4–5
days. The neutralization assays were carried out with similar
amounts of starting virions, in order to ensure that the starting
ratio of viral particles to antibodies is similar.
Quantitative reverse-transcriptase PCR
Total cDNA was produced as described above and analyzed by
quantitative PCR with iQ SYBR green supermix (Bio-rad)
containing 625 nM of each primer. Quantitative PCR reactions
were carried out under the following conditions: initial activation
of the Taq polymerase (Bio-Rad) at 95uC for 3 min followed by 45
cycles comprising one step of 95uC for 30 sec, one step of 56uC for
45 sec and one step of 72uC for 45 sec. Dissociation curves were
performed to check for the presence of a single peak corresponding
to the required amplicon.
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In parallel, fragments corresponding to both products were
quantified. On the one hand, a fragment corresponding to the
BoHV-4 Bo10 spliced product, was amplified with the forward
primer Bo10 23-43 and the reverse primer Bo10 SplicedOnlyRev.
On the other hand, the forward primer Bo10 intron sens
(59GTCCATGTGTGTTAAATCGGG39) and the reverse primer
Bo10 839-818 were used to amplify the specific Bo10 unspliced
product. In order to be able to compare amounts of both products,
a pGEM-T easy containing specific fragments of both Bo10
transcripts was constructed to establish a unique standard curve.
Briefly, we first introduced by T/A-cloning in pGEM-T-easy
vector a specific Bo10 spliced sequence generated by PCR on
cDNA with Bo10 PBDF and Bo10 Spliced Rev BamHI 59-
GGATCCTGGGAGGTTGTGTTGAAGAGT-39 as primers
resulting in pGEM-T spliced vector. Then a sequence specific of
Bo10 unspliced product was generated by using the Bo10 MuDir
cDNA as a template and Bo10 intron sens BamHI 59-GG-
ATCCGTCCATGTGTGTTAAATCGGG-39 and Bo10 PBDR
BamHI 59- GGATCCTCATAATAAATTATATCCCTGACTA-
TAATT-39 as primers. This PCR product was restricted with
BamHI and ligated into the BamHI site of the pGEM-T spliced
vector generating the pGEM-T spliced/unspliced plasmid.
To estimate the proportion of the spliced Bo10 transcript
relative to the ORF8 (encoding gB) and ORF47 (encoding gL)
transcripts, we amplified the Bo10 spliced as described above and
fragments corresponding to BoHV-4 ORF8 and ORF47 with the
forward primer 8startfw (59- CAAATAGTTCATTAGCTGCC-
TCTCC -39) and the reverse primer 8middlerev (59- TCATCAG-
TAACAGTTGGAATAGTGG -39), and with the forward primer
47startfw (59- AAGGATCCGCCGCCACCATGAGAGATATC-
TATGTTTTTTGT -39) and the reverse primer 47rev (59- AAC-
TCGAGCTATAATCTGCCCAGGCCAC -39) respectively. For
these comparisons, we used DNA from the BoHV-4 BAC G Bo10
Spliced plasmid as the unique standard curve.
For each comparison, serial dilutions of the standard curve were
made and the same amounts were used in the different reactions.
The numbers of copies have been determined based on the
measure of the DNA concentration of the standard curve.
Co-culture experiment
MDBK or BoMac cells in suspension were stained with PKH26
as described by the manufacturer. 1.105 labelled cells were
transferred into 6-well plates and then infected with the WT BAC
strain at a MOI of 1. Three hours post-infection, cells were washed
with acidic solution (PBS pH 3) in order to inactivate and remove
the inoculum. 12 hours post infection, 2.105 freshly isolated
PBMCs or MDBK controls were added. After 24 hours, the co-
cultivated cells were collected with a cell dissociation buffer
(Invitrogen) and stained by the Pacific Blue-conjugated anti-CD14
for FACS analysis.
Supporting Information
Figure S1 Protein contents of Bo10 MuDir and Bo10
Spliced virions. Purified virions of the WT BAC, Bo10 MuDir,
Bo10 MuDir Rev, Bo10 Spliced and Bo10 Spliced Rev strains
were compared for gp180 (with anti-Bo10-c15 serum) and gB
(with mAb 35) content per 106 PFU by immunoblotting as
described in the Methods. Anti-BoHV-4 polyserum was taken as
control. For each blot, the position of a molecular mass (MM)
standard (in kDa) is shown on the left.
(TIF)
Figure S2 Bo10 mRNA splicing determines BoHV-4
entry in CHO GAG2 cells. CHO-K1 cells (CHO GAG+)
and the GAG-deficient derivative CHO-pgsA-745 (CHO GAG2)
were infected at the MOI of 0.1 with WT BAC (black squares),
Bo10 MuDir (open circles), Bo10 MuDir Rev (black circles), Bo10
Spliced (open triangles) or Bo10 Spliced Rev (black triangles)
BoHV-4 strains for the times indicated and then washed with PBS.
Viral infection was assayed by measuring eGFP expression 18 h
later by flow cytometry. In order to compare the different strains,
the data are presented as percentages of the maximal values
measured for the WT BAC strain.
(TIF)
Figure S3 Effect of Bo10 mRNA splicing on rabbit
PBMCs infection. Rabbit PBMCs were infected with WT
BAC, Bo10 MuDir, Bo10 MuDir Rev, Bo10 Spliced and Bo10
Spliced Rev strains (1 PFU/cell). Twenty-four hours later, cells
were analyzed by flow cytometry for CD14 and viral eGFP
expression as described in the Methods. The data presented are
the average 6 SEMs for 6 measurements and were analyzed by
1way ANOVA and Bonferroni posttests, *** p,0.001.
(TIF)
Figure S4 Relative expression of the spliced Bo10
mRNA in MDBK and BoMac cells. MDBK and BoMac
cells were infected with the BoHV-4 V. test strain at a MOI of 1.
Twenty-four hours p.i., relative expressions of Bo10 spliced vs
ORF47 (gL) transcripts were estimated as described in the
Methods. The data presented are the average 6 SEMs for 3
measurements and were analyzed by Student’s t-test, ** p,0.01.
(TIF)
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